Pharma Equity Group 2025 Financial Calendar 14 January 2025 News Release Pharma Equity Group2025 Financial Calendar March 4Deadline for shareholder proposals - Annual General meeting March 20...
The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. The Board of Directors' decision on a new execution...
Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S...
Consolidated Interim report 1 January – 30 September 2024 Consolidated Interim report 1 January – 30 September 2024 Company announcement no. 30 – November 15, 2024 Key points from the Q1-Q3-2024...
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. Pharma Equity Group's...
Major shareholder announcement - Pharma Equity Group A/S Major shareholder announcement - Pharma Equity Group A/S 14 October 2024Announcement No. 28 Pharma Equity Group A/S has, in...
Managers’ transactions October 14,2024Announcement no. 27 Managers’ transactions Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014...
Pharma Equity Group announces successful completion of directed issue of new shares Pharma Equity Group announces successful completion of directed issue of new shares 11 October 2024Company...
Pharma Equity Group announces issuance of new shares in a direct issue Pharma Equity Group announces issuance of new shares in a direct issue Inside information4 October 2024Company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
4 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
12 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
26 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
52 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
156 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
260 | 0 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.